Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionSowell Financial Services LLC
Latest Disclosed Ownership14,591 shares
Latest Disclosed Value $ 2,033,586
Sowell Financial Services LLC reports 1.52% increase in ownership of GILD / Gilead Sciences, Inc.

On April 20, 2026 - Sowell Financial Services LLC filed a 13F-HR form disclosing ownership of 14,591 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,033,586 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 14,373 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.52% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F GILEAD SCIENCES COM 375558103 14,591 218 1.52 2,034 15.25 0.0752
2026-01-21 2025-12-31 13F GILEAD SCIENCES COM 375558103 14,373 5,573 63.33 1,764 80.74 0.0648
2025-10-17 2025-09-30 13F GILEAD SCIENCES COM 375558103 8,800 1,931 28.11 977 28.25 0.0375
2025-07-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 6,869 -1,273 -15.63 762 -16.56 0.0310
2025-04-17 2025-03-31 13F GILEAD SCIENCES COM 375558103 8,142 8,142 912 0.0415
2024-10-04 2024-09-30 13F GILEAD SCIENCES COM 375558103 0 -12,359 -100.00 0 -100.00
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 12,359 -475 -3.70 848 -9.79 0.0405
2024-05-03 2024-03-31 13F GILEAD SCIENCES COM 375558103 12,834 561 4.57 940 -5.43 0.0443
2024-01-24 2023-12-31 13F GILEAD SCIENCES COM 375558103 12,273 -6,167 -33.44 994 -28.08 0.0538
2023-11-08 2023-09-30 13F GILEAD SCIENCES COM 375558103 18,440 3,771 25.71 1,382 22.19 0.0867
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 14,669 3,706 33.80 1,131 0.0630
2023-05-12 2023-03-31 13F GILEAD SCIENCES STOCK 375558103 10,963 -7,284 -39.92 1 -100.00 0.0702
2023-02-09 2022-12-31 13F Gilead Sciences Stock 375558103 18,247 1,152 6.74 2 -99.91 0.1014
2022-11-15 2022-09-30 13F Gilead Sciences Stock 375558103 17,095 -9,502 -35.73 1,055 -35.83 0.1064
2022-08-15 2022-06-30 13F GILEAD SCIENCES Stock 375558103 26,597 26,597 1,644 0.1519
2022-05-13 2022-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 0 -13,405 -100.00 0 -100.00
2022-02-09 2021-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 13,405 2,963 28.38 973 33.47 0.0558
2021-11-04 2021-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 10,442 10,442 729 0.0492
2021-08-05 2021-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 0 -23,275 -100.00 0 -100.00
2021-05-07 2021-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 23,275 9,426 68.06 1,549 91.95 0.0539
2021-01-13 2020-12-31 13F GILEAD SCIENCES INC COM COM 375558103 13,849 -5,804 -29.53 807 -35.02 0.0345
2020-11-12 2020-09-30 13F GILEAD SCIENCES INC COM COM 375558103 19,653 7,636 63.54 1,242 34.27 0.0620
2020-08-13 2020-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 12,017 300 2.56 925 5.59 0.0508
2020-05-12 2020-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 11,717 787 7.20 876 23.38 0.0648
2020-02-07 2019-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 10,930 -3,823 -25.91 710 -24.06 0.0541
2019-11-14 2019-09-30 13F GILEAD SCIENCES INC COM COM 375558103 14,753 1,940 15.14 935 12.24 0.0773
2019-05-15 2019-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 12,813 697 5.75 833 9.89 0.0930
2019-03-05 2018-12-31 13F GILEAD SCIENCES COM 375558103 12,116 3,671 43.47 758 16.26 0.1074
2018-11-13 2018-09-30 13F GILEAD SCIENCES COM 375558103 8,445 684 8.81 652 8.85 0.0947
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 7,761 898 13.08 599 30.50 0.1271
2018-05-10 2018-03-31 13F GILEAD SCIENCES COM 375558103 6,863 2,235 48.29 459 22.07 0.1147
2018-01-29 2017-12-31 13F GILEAD SCIENCES COM 375558103 4,628 355 8.31 376 17.50 0.0919
2017-11-07 2017-09-30 13F GILEAD SCIENCES COM 375558103 4,273 1,185 38.37 320 41.59 0.0834
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 3,088 3,088 226 0.0641
2017-05-31 2017-03-31 13F Gilead Sciences COM 375558103 0 -1,175 -100.00 0 -100.00
2017-02-27 2016-12-31 13F Gilead Sciences COM 375558103 1,175 1,175 79 0.0265
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.